Skip to Main Content

Paper Details

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIXâ¿¢.
Cancer Immunol Immunother
35
2011

Datasets

Release 1.2